Search Results
Tuesday, May 24, 2022
Image
Participants of implanted neural device trials may have research-related care needs after the trial has ended. For example, these needs could include continued access to the device, device maintenance and support, explantation, and/or medical care resulting from participating in the research study. Discussions in the field suggest that…
… Director Dr. Chris Boshoff Health Program Specialists Ms. Shruthi Thomas Operations Coordinator Ms. Natasha Davis EOC Board Manager Ms. Oreisa O'Neil-Mathurin Project Managers Ms. Elena …
Friday, April 01, 2022
Image
NIH Program offers…
Thursday, May 05, 2022
Image
Date: May 5, 2022 | 12PM EDTRegistration
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biotherapeutics discovery and development, from lead optimization through phase…
Thursday, May 05, 2022
Image
The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics), which provides non-dilutive support for biologics neurotherapeutics discovery and development, from lead optimization through phase I clinical testing, held a Q&A Webinar for potential…
… Director Dr. Chris Boshoff Health Program Specialists Ms. Shruthi Thomas Operations Coordinator Ms. Natasha Davis EOC Board Manager Ms. Oreisa O'Neil-Mathurin Project Managers Ms. Elena …
Biologics Consultants support the translational development of novel biologics through technical recommendations and advice to PI and her/his team. Consultants provide feedback and guidance on project milestones, development strategy, study design, and data interpretation. Each Lead Development Team (LDT) receives support from BPN-Biologics consultants. Consultants are assigned to a project with consideration of the project team's individual needs and consultants' expertise.
Current NIH-contracted Biologics Consultants…
… for multiple CNS drug candidates supported by the NIH HEAL Initiative, including a highly complex pain program for … an intra-articular gene therapy drug candidate in the NIH HEAL program for pain due to osteoarthritis, including … of an oral small-molecule drug candidate in the NIH HEAL program, including providing feedback on late-stage …
File
This is a preview of the Data Table. Only the first three rows are displayed.
Title
Disorder
PI/Lead Investigator
Institution
Developing nonmuscle II inhibitors for substance use…
To ensure the proper response to your inquiries, please fill out the Pre-submission Communication Form(pdf, 236 KB) and email it to BPN Biologics Questions.
Please provide all information requested in the form, along with the specific questions…